Azita Saleki-Gerhardt
Chief Operating Officer at ABBVIE INC.
Net worth: 44 M $ as of 2024-03-30
Azita Saleki-Gerhardt active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ENTEGRIS, INC. | Director/Board Member | 2017-08-13 | - |
| Independent Dir/Board Member | 2017-08-13 | - | |
| ABBVIE INC. | Chief Operating Officer | 2023-06-30 | - |
| Corporate Officer/Principal | 2023-06-28 | 2023-06-30 | |
AbbVie Deutschland GmbH & Co. KG
 AbbVie Deutschland GmbH & Co. KG BiotechnologyHealth Technology Part of AbbVie, Inc., AbbVie Deutschland GmbH & Co. KG is a German company that focuses on treating plaque psoriasis, a chronic inflammatory skin disease that cannot be cured but can be managed effectively. The private company is based in Wiesbaden, Germany. The CEOs of the company are Thomas Scheidmeir, Stefan Simianer. | Chairman | - | - |
| United Way of Lake County | Director/Board Member | - | - |
Career history of Azita Saleki-Gerhardt
Former positions of Azita Saleki-Gerhardt
| Companies | Position | Start | End |
|---|---|---|---|
| ABBOTT LABORATORIES | Corporate Officer/Principal | 2003-12-31 | 2011-12-31 |
Training of Azita Saleki-Gerhardt
| University of Wisconsin | Doctorate Degree |
Statistics
International
| United States | 6 |
| Germany | 2 |
Operational
| Corporate Officer/Principal | 2 |
| Director/Board Member | 2 |
| Independent Dir/Board Member | 1 |
Sectoral
| Health Technology | 4 |
| Producer Manufacturing | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| ENTEGRIS, INC. | Producer Manufacturing |
| ABBVIE INC. | Health Technology |
| Private companies | 2 |
|---|---|
| United Way of Lake County | |
AbbVie Deutschland GmbH & Co. KG
AbbVie Deutschland GmbH & Co. KG BiotechnologyHealth Technology Part of AbbVie, Inc., AbbVie Deutschland GmbH & Co. KG is a German company that focuses on treating plaque psoriasis, a chronic inflammatory skin disease that cannot be cured but can be managed effectively. The private company is based in Wiesbaden, Germany. The CEOs of the company are Thomas Scheidmeir, Stefan Simianer. | Health Technology |